Related Experiment Video
Updated: Jan 20, 2026

Imaging Dpp Release from a Drosophila Wing Disc
Published on: October 30, 2019
Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity
Habib Yaribeygi1, Thozhukat Sathyapalan2, Amirhossein Sahebkar3
1Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.
Abstract:
Glucagon-like peptide-1 is a peptide of incretin family which is used in the management of diabetes as glucagon-like peptide-1 receptor agonist (GLP-1RA). Dipeptidyl peptidase-4 enzyme metabolizes glucagon-like peptide-1 and various dipeptidyl peptidase-4 enzyme inhibitors (DPP-4i) are also used in the management of diabetes. These antidiabetic agents provide anti-hyperglycemic effects via several molecular mechanisms including promoting insulin secretion, suppression of glucagon secretion and slowing the gastric emptying. There is some research suggesting that they can induce insulin sensitivity in peripheral tissues. In this study, we review the possible molecular mechanisms by which GLP-1RA and DPP-4i can improve insulin resistance and increase insulin sensitivity in insulin-dependent peripheral tissues.
Related Concept Videos
SN1 Reaction: Mechanism
Firstly, the haloalkane ionizes to generate a carbocation intermediate and a halide ion. This heterolytic cleavage is highly endothermic with large activation energy. The ionization of the substrate, facilitated by a...
Mechanisms of Retrovirus-induced Cancers
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Mechanism
1° Amines to Diazonium or Aryldiazonium Salts: Diazotization with NaNO2 Mechanism
Insulin Secretory Vesicles
Molecular Orbital Theory II

